LLVK TFA is a selectiveIκB phosphorylationinhibitor. LLVK TFA reduces LPS-induced pro-inflammatory cytokines (IL-1β,IL-6, TNF-α). LLVK TFA is promising for research of inflammatory bowel disease and rheumatoid arthritis[1].
References:
[1].Liu W, et al. Alternation in sequence features and their influence on the anti-inflammatory activity of soy peptides during digestion and absorption in different enzymatic hydrolysis conditions. Food Chem. 2025 Apr 15;471:142824.
LLVK TFA 是一种选择性的IκB phosphorylation抑制剂。LLVK TFA 能降低 LPS 引发的促炎性细胞因子 (IL-1β、IL-6、TNF-α)。LLVK TFA 有望用于炎症性肠病和类风湿性关节炎的研究。